Inhibition of hypoxia inducible factor-1α (HIF-1α) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas
The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Abstract
Introduction Hypoxia inducible factor-1alpha (HIF-1alpha) regulates vascular endothelial growth factor (VEGF), the presumed principal mediator of angiogenesis in malignant gliomas, under normal physiologic conditions. We examined the effect of HIF-1alpha on VEGF secretion, tumor growth, and angiogenesis in malignant gliomas.Methods We examined 175 human gliomas for expression of HIF-1alpha and its downstream-regulated proteins. HIF-1alpha expression and VEGF secretion in glioma cell lines under normoxia and hypoxia were examined using ELISA and Western blot. Malignant glioma cell lines were transfected with dominant-negative HIF-1alpha (DN-HIF-1alpha) expression vector or siRNA constructs against the HIF-1alpha gene. Growth studies were conducted on cells with the highest VEGF/HIF-1alpha inhibition isolated from stable transfected cell lines. MIB-1-labeling index and microvascular density (MVD) measurements were performed on the in vivo tumors.Results HIF-1 expression correlates with malignant glioma phenotype and was not confined to perinecrotic, pseudopalisading cells. VEGF and HIF-1 expression was high in glioma cell lines even under normoxia, and increased after exposure to hypoxia or growth factor stimulation. Cells transfected with DN-HIF-1alpha or HIF-1alpha siRNA demonstrated decreased HIF-1alpha and VEGF secretion. In vivo but not in vitro growth decreased in response to VEGF and HIF-1 inhibition. HIF-1 siRNA studies showed decreased VEGF secretion and in vitro and in vivo growth of glioma cell lines. MVD was unchanged but MIB-1 proliferation index decreased for both types of HIF-1 inhibition.Conclusions VEGF and HIF-1alpha are elevated in malignant gliomas. HIF-1alpha inhibition results in VEGF secretion inhibition. HIF-1alpha expression affects glioma tumor growth, suggesting clinical applications for malignant glioma treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, decreasing HIF transcriptional activity through antisense, dominant-negative, or short interfering RNA constructs (12, 14, 27, 30, 39) slows tumor progression.”
From Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis (2008) · cites this paper as [27]
Citations
Cites
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627 · cited 1×
“The MVD was calculated based on a method described previously [12].”
MethodActivation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981 · cited 3×
“The DN form of HIF-1a, pCEP4/HIF-1aDN, was constructed by replacing the sequences encoding the basic domain of HIF-1a with a double-stranded, 16-base-pair oligonucleotide and deleting the sequences encoding the carboxyl terminus of HIF-1a (Figure 1) [5,17].”
BackgroundMethodRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 1×
“Physiologic induction of VEGF expression in response to hypoxia seems to require HIF-1a regulation [7,9].”
Background(1999) · PubMed · Cited by 2,204
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · cited 1×
“HIF-1a and HIF-1b mRNA are both constitutively expressed and do not seem to be significantly modified by hypoxia [33].”
BackgroundHIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822 · cited 1×
“Heterodimers of the DN HIF-1a and HIF-1b are biologically inactive because of the loss of DNA-binding activity [17,18,19].”
BackgroundHIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
The WHO classification of tumors of the nervous system
Kleihues, P., Louis, D. N., Scheithauer, B. W., Rorke, L. B., Reifenberger, G., Burger, P. C., & Cavenee, W. K. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.215 · Cited by 1,547
(2000) · PubMed · Cited by 1,445
(1964) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb115841.x · Cited by 1,409
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
Millauer, B., Shawver, L. K., Plate, K. H., Risaui, W., & Ullrich, A. (1994) · Nature · doi:10.1038/367576a0 · Cited by 1,221
Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1
Jiang, B.-H., Rue, E., Wang, G. L., Roe, R., & Semenza, G. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17771 · Cited by 1,106 · cited 3×
“Heterodimers of the DN HIF-1a and HIF-1b are biologically inactive because of the loss of DNA-binding activity [17,18,19].”
BackgroundMethodMaxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084 · cited 1×
“HIF-1a activation has been demonstrated in hypoxic regions of a number of tumors including GBM and is a major influence on VEGF expression, tumor angiogenesis, and xenograft tumor growth [ 8 ,40].”
BackgroundHypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.
Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., & Johnson, R. S. (2000) · PubMed · Cited by 903
Loss of PTEN facilitates HIF-1-mediated gene expression
Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., et al. (2000) · Genes & Development · doi:10.1101/gad.14.4.391 · Cited by 840 · cited 1×
“PTEN negatively regulates the phosphatidylinositol 3-kinase (PI3K)-mediated signal transduction pathways, which are implicated in VEGF and HIF-1a expression and subsequent angiogenesis in nonglioma cells [40,48] and recently in a glioma cell line [43].”
BackgroundStabilization of wild-type p53 by hypoxia-inducible factor 1α
An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., & Neckers, L. M. (1998) · Nature · doi:10.1038/32925 · Cited by 827
Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2.
Feldser, D. M., Agani, F. H., Iyer, N. V., Pak, B. J., Ferreira, G., & Semenza, G. L. (1999) · PubMed · Cited by 801
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761 · cited 1×
“Mutations of p53 correlate with VEGF or HIF-1a overexpression in some human cancers, including the few GBM tumors studied [48,49].”
BackgroundHypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
Kaur, B., Khwaja, F. W., Severson, E. A., Matheny, S. L., Brat, D. J., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001115 · Cited by 725
(2000) · PubMed · Cited by 614
Jiang, B., Agani, F. H., Passaniti, A., & Semenza, G. L. (1997) · PubMed · Cited by 610
Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., & Semenza, G. L. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2606::aid-cncr25>3.0.co;2-w · Cited by 604 · cited 1×
“The immunohistochemical analysis of HIF-1a was scored as follows: 0, no staining; 1, nuclear-positive cells in less than 1% of population; 2, nuclear-positive cells in 1–10% and/or weak cytoplasm staining; 3, nuclear-positive cells in 10–50% and/or distinct cytoplasm staining; 4, nuclearpositive cells in more than 50%…”
BackgroundInsulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha /ARNT
Zelzer, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5085 · Cited by 575 · cited 1×
“In several nonglioma cell types, HIF-1a and, subsequently, VEGF expression can be induced by stimulation of growth factors such as PDGF, IGF1, and IGF2 to a level higher than that found after hypoxic stimulation [36,48, 56 ].”
BackgroundExpression of hypoxia-inducible factor 1: mechanisms and consequences
Semenza, G. L. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00292-0 · Cited by 511 · cited 1×
“Greg Semenza kindly provided the pCEP-4 plasmids containing wild-type (WT) and dominant-negative (DN) HIF-1a constructs [16].”
BackgroundRichard, D. E., Berra, E., & Pouysségur, J. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61441-9 · Cited by 488
Brat, D. J., Castellano-Sanchez, A. A., Hunter, S. B., Pecot, M., Cohen, C., Hammond, E. H., Devi, S. N., Kaur, B., & Van Meir, E. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2073 · Cited by 485
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
Arbiser, J. L., Moses, M. A., Fernandez, C. A., Ghiso, N., Cao, Y., Klauber, N., Frank, D., Brownlee, M., Flynn, E., Parangi, S., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.861 · Cited by 469 · cited 1×
“VEGF secretion is up-regulated in nonglioma cell lines expressing constitutively activated oncogenes [29,54].”
BackgroundBerkman, R. A., Merrill, M. J., Reinhold, W. C., Monacci, W. T., Saxena, A., Clark, W. C., Robertson, J. T., Ali, I. U., & Oldfield, E. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116165 · Cited by 461 · cited 1×
“Elevated expression of VEGF is found in GBM tumors and cell lines compared with expression in lower-grade tumors [23,24].”
(2002) · PubMed · Cited by 457
Kimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T., D'Acquisto, F., Addeo, R., Makuuchi, M., & Esumi, H. (2000) · Blood · doi:10.1182/blood.v95.1.189 · Cited by 439
Ojeda, V. J. (1988) · Pathology · doi:10.1016/s0031-3025(16)36608-9 · Cited by 418
The hypoxic response of tumors is dependent on their microenvironment
Blouw, B., Song, H., Tihan, T., Bosze, J., Ferrara, N., Gerber, H.-P., Johnson, R. S., & Bergers, G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00194-6 · Cited by 408 · cited 2×
“In a similar study, a model of GBM was created using genetically engineered transformed astrocytes with loss of either HIF-1 or VEGF function [59].”
BackgroundMethodPR39, a peptide regulator of angiogenesis
Li, J., Post, M., Volk, R., Gao, Y., Li, M., Metais, C., Sato, K., Tsai, J., Aird, W., Rosenberg, R. D., et al. (2000) · Nature Medicine · doi:10.1038/71527 · Cited by 386 · cited 1×
“During low oxygen tension (1–2% O2) conditions, this degradation is inhibited, leading to increased HIF-1a, which translocates to the nucleus to activate gene transcription [34,35].”
BackgroundHypoxia Is Important in the Biology and Aggression of Human Glial Brain Tumors
Evans, S. M., Judy, K. D., Dunphy, I., Jenkins, W. T., Hwang, W.-T., Nelson, P. T., Lustig, R. A., Jenkins, K., Magarelli, D. P., Hahn, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1081 · Cited by 356
Mechanisms of Angiogenesis in the Brain
Plate, K. H. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199904000-00001 · Cited by 353
Maity, A. M., Pore, N., Lee, J. S. H., Solomon, D., & O’Rourke, D. M. (2000) · PubMed · Cited by 333
p53 Inhibits Hypoxia-inducible Factor-stimulated Transcription
Blagosklonny, M. V., An, W. G., Romanova, L. Y., Trepel, J., Fojo, T., & Neckers, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.11995 · Cited by 283 · cited 1×
“Evidence suggests that p53 inhibits HIF-1-mediated transcription, and loss of p53 can increase downstream HIF-1-related gene activity [14,50].”
BackgroundAngiogenesis: How a Tumor Adapts to Hypoxia
Richard, D. E., Berra, E., & Pouysségur, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1889 · Cited by 280 · cited 1×
“During low oxygen tension (1–2% O2) conditions, this degradation is inhibited, leading to increased HIF-1a, which translocates to the nucleus to activate gene transcription [34,35].”
Background(1999) · PubMed · Cited by 258
Duyckaerts, C., & Boller, F. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00603_6.x · Cited by 245
Identification of a Novel Small-Molecule Inhibitor of the Hypoxia-Inducible Factor 1 Pathway
Tan, C., de Noronha, R. G., Roecker, A. J., Pyrzynska, B., Khwaja, F., Zhang, Z., Zhang, H., Teng, Q., Nicholson, A. C., Giannakakou, P., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.605.65.2 · Cited by 225 · cited 1×
“Inhibition of HIF-1 by small-molecule inhibitors and siRNA techniques similar to those used in this study has been employed to decrease in vivo tumor growth [60, 61 ].”
MethodComparative Measurements of Hypoxia in Human Brain Tumors Using Needle Electrodes and EF5 Binding
Evans, S. M., Judy, K. D., Dunphy, I., Jenkins, W. T., Nelson, P. T., Collins, R., Wileyto, E. P., Jenkins, K., Hahn, S. M., Stevens, C. W., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2424 · Cited by 216
Blum, R., Jacob‐Hirsch, J., Amariglio, N., Rechavi, G., & Kloog, Y. (2005) · PubMed · Cited by 178
Chan, A. S. Y., Leung, S. Y., Wong, M. P., Yuen, S. T., Cheung, N., Fan, Y. W., & Chung, L. P. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199807000-00004 · Cited by 177 · cited 3×
“Both VEGF and HIF-1a expression are highest in the presumed hypoxic areas immediately adjacent to necrotic foci in a subpopulation of glioblastoma tumors known as palisading cells [3,41].”
BackgroundMizukami, Y., Li, J., Zhang, X., Zimmer, M. A., Iliopoulos, O., & Chung, D. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3017 · Cited by 165
Blum, R., Jacob-Hirsch, J., Amariglio, N., Rechavi, G., & Kloog, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.999.65.3 · Cited by 161 · cited 1×
“Growth factor-mediated or -activated oncogene activity is another potential source of VEGF/HIF-1a overexpression [ 53 ].”
BackgroundMouillet-Richard, S., Mutel, V., Loric, S., Tournois, C., Launay, J.-M., & Kellermann, O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9186 · Cited by 130
Zhang, X., Kon, T., Wang, H., Li, F., Huang, Q., Rabbani, Z. N., Kirkpatrick, J. P., Vujaskovic, Z., Dewhirst, M. W., & Li, C.-Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2301 · Cited by 120 · cited 1×
“Inhibition of HIF-1 by small-molecule inhibitors and siRNA techniques similar to those used in this study has been employed to decrease in vivo tumor growth [ 60 ,61].”
MethodHypoxia regulates gene expression of alveolar epithelial transport proteins.
Clérici, C., & Matthay, M. (2000) · Journal of applied physiology · doi:10.1152/jappl.2000.88.5.1890 · Cited by 108 · cited 3×
“It has been suggested that this might be an artifact of cultured cells, which are in relatively hypoxic conditions because of the presence of overlying culture medium [32], but other cultured cells that we have studied, such as the primary meningioma cells, do not show this normoxic expression of HIF-1a.”
BackgroundInfluentialKorkolopoulou, P., Patsouris, E., Konstantinidou, A. E., Pavlopoulos, P. M., Kavantzas, N., Boviatsis, E., Thymara, I., Perdiki, M., Thomas‐Tsagli, E., Angelidakis, D., et al. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2003.00535.x · Cited by 95
Expression of vascular endothelial growth factor in human brain tumors
Nishikawa, R., Cheng, S., Nagashima, R., Huang, H., Cavenee, W. K., & Matsutani, M. (1998) · Acta Neuropathologica · doi:10.1007/s004010050919 · Cited by 95 · cited 1×
“Elevated expression of VEGF is found in GBM tumors and cell lines compared with expression in lower-grade tumors [23,24].”
Expression of hypoxia‐inducible factor 1α in tumours of patients with glioblastoma
Søndergaard, K. L., Hilton, D. A., Penney, M., Ollerenshaw, M., & Demaine, A. G. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00391.x · Cited by 87 · cited 1×
“VEGF secretion in human glioma cell cultures can be induced by physiological concentrations of EGF, PDGF-BB, and FGF [ 25 ,55].”
BackgroundLund, E. L., Høg, A. M., Olsen, M. W. B., Hansen, L. T., Engelholm, S. A., & Kristjansen, P. E. G. (2004) · International Journal of Cancer · doi:10.1002/ijc.11662 · Cited by 84 · cited 1×
“This is consistent with glioma cell line work with similar findings [ 22 ].”
ResultLi, K., Shi, Y. X., Im, S., Chen, X., & Yung, W. K. A. (2000) · PubMed · Cited by 82
Ibuprofen: effect on inducible nitric oxide synthase
Stratman, N. C., Carter, D. B., & Sethy, V. H. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00168-x · Cited by 79 · cited 1×
“Both VEGF and HIF-1a expression are highest in the presumed hypoxic areas immediately adjacent to necrotic foci in a subpopulation of glioblastoma tumors known as palisading cells [3, 41 ].”
BackgroundNewcomb, E. W., Ali, M. A., Schnee, T., Lan, L., Lukyanov, Y., Fowkes, M., Miller, D. C., & Zagzag, D. (2005) · Neuro-Oncology · doi:10.1215/s1152851704000997 · Cited by 72
Binding and regulation of HIF‐1α by a subunit of the proteasome complex, PSMA7
Cho, S., Choi, Y.-J., Kim, J.-M., Jeong, S.-T., Kim, J.-H., Kim, S.-H., & Ryu, S.-E. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02499-1 · Cited by 61 · cited 1×
“This construct acts presumably by competing with the endogenous HIF-1a for heterodimerization with endogenous HIF- 1b. Heterodimers of the DN HIF-1a and HIF-1b are biologically inactive because of the loss of DNA-binding activity [17,18, 19 ].”
BackgroundHypoxia in a human intracerebral glioma model
Bernsen, H. J. J. A., Rijken, P. F. J. W., Peters, H., Raleigh, J. A., Jeuken, J. W. M., Wesseling, P., & van der Kogel, A. J. (2000) · Journal of Neurosurgery · doi:10.3171/jns.2000.93.3.0449 · Cited by 46
Kanno, H., Shuin, T., Kondo, K., Yamamoto, I., Ito, S., Shinonaga, M., Yoshida, M., & Yao, M. (1997) · PubMed · Cited by 42
Matrigel Augments Xenograft Transplantation of Meningioma Cells into Athymic Mice
Jensen, R. L., Leppla, D. C., Rokosz, N., & Wurster, R. D. (1998) · Neurosurgery · doi:10.1097/00006123-199801000-00027 · Cited by 38 · cited 2×
“Our previous work demonstrated that Matrigel by itself does not form tumors and is not found histologically two weeks after implantation [20].”
BackgroundSelf-citationParliament, M. B., Franko, A. J., Allalunis‐Turner, M. J., Bw, M., Santos, C. G. Y., Wolokoff, B., & Mercer, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.52 · Cited by 38
Gaddipati, J. P., Madhavan, S., Sidhu, G. S., Singh, A., Seth, P., & Maheshwaril, R. K. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006982028460 · Cited by 37 · cited 2×
“The effects of growth factor stimuli on VEGF secretion and HIF-1a expression were assessed by growing cells with media containing epidermal growth factor (EGF) (0.5 to 50 ng/ml), basic fibroblast growth factor (bFGF) (0.5 to 50 ng/ml), or plateletderived growth factor BB (PDGF-BB) (0.5 to 50 ng/ml) in triplicate wells.”
BackgroundInfluentialJensen, R. L., Lee, Y. S., Guijrati, M., Origitano, T. C., Wurster, R. D., & Reichman, O. H. (1995) · Neurosurgery · doi:10.1227/00006123-199511000-00013 · Cited by 33 · cited 1×
“Tumor cells were obtained from the operating room and established as primary cultures as described previously [13].”
MethodSelf-citationFults, D., & Pedone, C. A. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.2.71 · Cited by 25 · cited 1×
“PTEN/MMAC1 (phosphatase and tensin homolog/mutated in multiple advanced cancers) tumor suppressor gene loss is demonstrated in 25–60% of GBM tumors studied [51,52].”
BackgroundBernsen, H. J. J. A., Rijken, P. F. J. W., Peters, J. P. W., Bakker, H. H., & van der Kogel, A. J. (1998) · Neurosurgery · doi:10.1097/00006123-199809000-00094 · Cited by 21
Cited by
Ziello, J. E., Jovin, I. S., & Huang, Y. (2007) · PubMed Central · Cited by 909
Hypoxia: A key regulator of angiogenesis in cancer
Liao, D., & Johnson, R. S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9066-y · Cited by 721
“Histological studies of human cancers have correlated increased tumor expression of HIF-1α and VEGF with more aggressive and malignant lesions [22, 23].”
BackgroundGuzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01338-07 · Cited by 427
“Conversely, decreasing HIF transcriptional activity through antisense, dominant-negative, or short interfering RNA constructs (12, 14, 27 , 30, 39) slows tumor progression.”
BackgroundHypoxia-Inducible Factors and Cancer
Jun, J. C., Rathore, A., Younas, H., Gilkes, D., & Polotsky, V. Y. (2017) · Current Sleep Medicine Reports · doi:10.1007/s40675-017-0062-7 · Cited by 248
Yang, L., Lin, C., Wang, L., Guo, H., & Wang, X. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.07.017 · Cited by 178
Metadata
- Authors
- Jensen, R. L., Ragel, B. T., Whang, K., & Gillespie, D.
- Affiliations
- University of Utah (US)
- Yonsei University (KR)
- Corresponding author
- Jensen, Randy L.
- Venue
- Journal of Neuro-Oncology
- Published
- 2006-04-13
- Volume
- 78
- Issue
- 3
- Pages
- 233-247
- ISSN
- 0167-594X (ISSN-L)
- 1573-7373
- OpenAlex
- W2071045537
- Cited by
- 167
- References
- 66
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 8 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 8 · 2016: 7 · 2015: 4 · 2014: 11 · 2013: 10 · 2012: 15
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neuro-Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Keywords
- hypoxia-inducible factor-1α, vascular endothelial growth factor, high-grade glioma, tumor angiogenesis, tumor growth, hypoxia, siRNA knockdown, microvessel density, cell proliferation, glioma cell lines
- MeSH terms
- Adult, Aged, Aged, 80 and over, Hypoxia, Brain Neoplasms, Female, Glioma, Humans, Immunohistochemistry, Male, Middle Aged, Neovascularization, Pathologic, Tumor Cells, Cultured, Gene Expression Regulation, Neoplastic, Ki-67 Antigen, Gene Silencing, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.